This act mandates the FAA to create and annually update a public list of medications deemed safe for pilots and air traffic controllers to use while maintaining their medical certification.
Sean Casten
Representative
IL-6
The Aviation Medication Transparency Act of 2025 mandates the Federal Aviation Administration (FAA) to create and maintain a public list of medications deemed safe for pilots and air traffic controllers to use while maintaining their medical certification. This list must be developed in consultation with relevant industry and labor groups. The FAA is required to update this comprehensive list annually, ensuring airmen and their doctors have clear guidance on medication approval status and necessary waiting periods.
The Aviation Medication Transparency Act of 2025 is setting a new standard for how the Federal Aviation Administration (FAA) handles medical certification for airmen—that’s pilots and air traffic controllers. Essentially, the bill says the FAA has to stop being vague about what medications are okay to take and what aren't. No later than one year after enactment, the FAA Administrator must publish and maintain a public, comprehensive list of approved medications and treatments that airmen can use while still maintaining their medical certification. This is a big deal for aviation safety and for the careers of thousands of professionals.
For anyone working in aviation safety, getting a medical certificate is a high-stakes annual event. Right now, the rules around medications can feel like a guessing game, creating massive stress for airmen who need to manage common conditions like depression, anxiety, or high blood pressure. This bill changes that by requiring the FAA to clearly list approved medications and, crucially, what’s on the “Do Not Issue” list—the meds that automatically disqualify someone. They also have to include details like the average waiting time an airman might need to be grounded or on limited duties while stabilizing on a new approved drug. Think of it as finally getting a clear user manual instead of having to call tech support every time you need an answer.
This isn't just the FAA putting out a list unilaterally. The legislation mandates that the FAA draft this list after consulting with key stakeholders, including the union representing air traffic controllers, the largest union representing airline pilots, and the Aeromedical Innovation and Modernization Working Group. This consultation requirement, found in Section 2, is vital because it ensures the rules are practical and informed by the people who actually have to live by them. For a pilot managing a chronic condition, having their union at the table means the resulting list will hopefully be grounded in both medical science and real-world operational realities. The bill also requires the FAA to provide a direct way for doctors to contact them with questions, which should help treating physicians who often struggle to interpret complex aviation regulations.
For a 35-year-old air traffic controller recently diagnosed with a condition requiring daily medication, this legislation provides peace of mind. Instead of facing weeks or months of uncertainty and potentially losing their job while waiting for the FAA to review their case, they can look up the approved medication list immediately. If their doctor prescribes a drug on the approved list, they know their career isn't immediately jeopardized. The FAA must also review and update this list annually, ensuring that the guidance keeps up with modern medicine. The biggest challenge here is on the FAA, which now has a significant administrative burden to create and maintain this complex, medically sensitive database on a strict yearly schedule. However, for the airmen, this move toward transparency is a huge step forward in reducing career risk associated with seeking necessary medical treatment.